We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2007 by Hospital Militar de Santiago.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00591487
First Posted: January 11, 2008
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hospital Militar de Santiago
  Purpose
RCT of S/E of lidocaine infiltration in tumescent technique.

Condition Intervention Phase
Healthy Drug: Lidocaine Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy With Tumescent Technique. A Randomized, Double Blinded, Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Hospital Militar de Santiago:

Primary Outcome Measures:
  • Pain (VSA) [ Time Frame: 1, 6, 12, 18 and 24 post operative hours ]

Secondary Outcome Measures:
  • Rescue medication [ Time Frame: 1, 6, 12, 15 and 24 hours postoperative ]
  • Nausea, emesis, arrythmia, seizures, arrest, shock, death. [ Time Frame: 24 hours postoperative ]

Estimated Enrollment: 60
Study Start Date: December 2007
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: I
Infiltration with 0.9% saline+1:1,000,000 epinephrine+0.06% Lidocaine
Drug: Lidocaine
Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.
Placebo Comparator: II
Infiltration with 0.9% saline+1:1,000,000 epinephrine
Drug: Lidocaine
Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Woman
  • I or II of the Classification of the American Society of Anesthesiologists.
  • Completed high school.
  • Between 18 and 40 years old
  • At least suction of entire abdomen and back
  • Body mass index between 20 and 27
  • Accept written informed consent

Exclusion Criteria:

  • Associated surgery
  • Hypersensibility to (Cefazolin or Clindamycin, Lidocaine, Ketorolac, Morphine, Remifentanyl, Propofol, Tramadol).
  • Pregnancy
  • Previous surgery to abdominal wall or back, including cesarean.
  • Abdominal wall hernia
  • Previous liposuction
  • Active psychosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00591487


Locations
Chile
Hospital Militar de Santiago
Santiago, RM, Chile
Sponsors and Collaborators
Hospital Militar de Santiago
Investigators
Principal Investigator: Stefan Danilla, MD, MSc Hospital Militar de Santiago
Study Chair: Guillermo Israel, MD Hospital Militar de Santiago
Study Chair: Montserrat Fontbona, MD Hospital Militar de Santiago
Study Director: Rodrigo Cabello, MD Hospital Militar de Santiago
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stefan Danilla, MD, MSc, Hospital Militar de Santiago
ClinicalTrials.gov Identifier: NCT00591487     History of Changes
Other Study ID Numbers: HMS-LIPO-001
First Submitted: December 31, 2007
First Posted: January 11, 2008
Last Update Posted: October 12, 2017
Last Verified: December 2007

Keywords provided by Hospital Militar de Santiago:
suction
assisted
lipectomy
liposuction
contour
cosmetic
plastic
surgery
Klein
tumescent
technique
Healthy women wanting Suction Assisted Lipectomy

Additional relevant MeSH terms:
Lidocaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action